NCT02709798View on ClinicalTrials.gov

ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Myocardial Infarction
Interventions
DRUG

Shenfu Injection

DRUG

5% Glucose Injection

Trial Locations (1)

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

INDUSTRY

lead

Beijing Anzhen Hospital

OTHER

NCT02709798 - ShenFu Injection for Myocardial Protection in Patients With Acute ST Segment Elevation Myocardial Infarction | Biotech Hunter | Biotech Hunter